Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 221 ~ 240 of 1696, Page 12 of 86
221. Study Finds Association Between C-Reactive Protein and Cancer Risk, Mortality
A summary of a study published online March 16, 2009 in the Journal of Clinical Oncology showed that high levels of C-reactive protein, a marker for inflammation and heart disease risk, may also be associated with the risk of developing cancer and with earlier cancer death.
03/20/2009 American Society of Clinical Oncology (ASCO)
222. FDA Assessing Feasibility of Using Nanotechnology Test to Detect Anthrax Following a Bioterrorist Attack
Test might be adaptable for use in resource-limited environments
03/17/2009 U. S. Food and Drug Administration (FDA)
223. FDA Approved First DNA Test for Two Types of Human Papillomavirus
Agency also approved second DNA test for wider range of HPV types
03/13/2009 U. S. Food and Drug Administration (FDA)
224. FDA Posts Quarterly Reports of Potential Drug Safety Issues
02/06/2009 U. S. Food and Drug Administration (FDA)
225. ASCO Releases Provisional Clinical Opinion Recommending Routine KRAS Gene Testing to Guide Treatment for Metastatic Colorectal Cancer
01/14/2009 American Society of Clinical Oncology (ASCO)
226. Checklist helps reduce surgical complications, deaths
Surgical adverse events reduced by one third in trials in eight countries
01/14/2009 World Health Organization (WHO)
227. Advances in the Treatment of Gastrointestinal Cancers
Routine KRAS Testing in Patients with Metastatic Colorectal Cancer Could Save $604 Million in Drug Costs Annually; Gene Mutations Link GERD and Esophageal Cancer; Octreotide LAR Slows Cancer Growth in Patients with Rare Neuroendocrine Tumors; Genetic Variations May Predict Survival, Outcomes for People with Pancreatic Cancer
01/13/2009 American Society of Clinical Oncology (ASCO)
228. FDA Approves First Nucleic Acid Test to Screen for Additional Types of HIV in Donated Blood and Tissue
12/30/2008 U. S. Food and Drug Administration (FDA)
229. Breakthrough of the Year: Cellular Reprogramming
Cellular Reprogramming Leads Science List of Top 10 2008 Breakthroughs
12/18/2008 American Association for the Advancement of Science (AAAS)
230. Have Numbness, Pain or Muscle Weakness? Guidelines Identify Best Tests for Neuropathy
12/04/2008 American Academy of Neurology (AAN)
231. Companies spurn low-tech HIV tests
Cheap, effective tests for patients in Africa too unprofitable.
12/04/2008 News@nature.com, Nature Publishing Group (NPG)
232. A speedier test for heparin contamination?
Alternative method is easier and faster, but questions remain over its sensitivity.
12/03/2008 News@nature.com, Nature Publishing Group (NPG)
233. ACP Recommends Routine HIV Screening for All Patients
12/01/2008 American College of Physicians (ACP)
234. Universal voluntary testing, immediate treatment can reduce HIV cases
New findings, based on mathematical model, published for discussion and further research
11/26/2008 World Health Organization (WHO)
235. Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
New research suggests that common genetic variants associated with type 2 diabetes were a little more effective in predicting future development of the disease than risk factors ...
11/25/2008 American Diabetes Association (ADA)
236. Blood Viscosity and Hematocrit as Risk Factors for Type 2 Diabetes Mellitus
Researchers suggest that elevated blood viscosity may be an independent risk factor for type 2 diabetes by decreasing the delivery of glucose, insulin, and oxygen to tissues.&nbs ...
11/25/2008 American Diabetes Association (ADA)
237. FDA Approves New Drug to Alleviate Moderate to Severe Pain
11/24/2008 U. S. Food and Drug Administration (FDA)
238. AAP Policy Statement Recommends Prenatal Testing, Immediate Intervention to Prevent Mother-child HIV Transmission
11/03/2008 American Academy of Pediatrics (AAP)
239. Second Annual Meeting on Molecular Markers Highlights in Advances in Personalized Cancer Medicine
KRAS Status Predicts Panitumumab Response in Colorectal Cancer Patients; EGFR Mutations in Blood Could Identify Lung Cancer Patients Most Likely to Respond to Erlotinib; Tumor Protein May Identify Patients Who Could be Spared Difficult Pancreatic Cancer Surgery
10/28/2008 American Society of Clinical Oncology (ASCO)
240. FDA Creates Web Page with Drug Safety Information for Patients, Health Care Professionals
Consolidates information in one access point
10/15/2008 U. S. Food and Drug Administration (FDA)
   
11 12 13 14 15 16 17 18 19 20
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱